JPRN-UMIN000026404已完成2 期
Efficacy and safety of transarterial chemoembolization + vitamin K combination treatment against hepatocellular carcinoma-Open label, randomized, phase 2 study - TACE + vitamin K treatment
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 101
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18years-old 至 85years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Patients who underwent previous transarterial chemoenmbolization greater than twice, patients with warfarin dosing, patients who have been given vitamin K before the enrollment
研究者
相似试验
招募中
4 期
A clinical study to evaluate the effect of cTACE with Lipiodol in treatment of HCC patientsCTRI/2020/10/028544GUERBET
招募中
2 期
Efficacy of transcatheter arterial chemoembolization (TACE) with miriplatin for multiple hepatocellular carcinoma refractory or inappropriate to conventional TACEMultiple hepatocellular carcinomaJPRN-UMIN000010291Department of Surgery, Graduate School of Medicine Kyoto University20
已完成
不适用
TACE in Combination With PD-1/PD-L1 Inhibitors and Molecular Target Therapies for Intermediate HCCHepatocellular CarcinomaNCT05332496Zhongda Hospital941
已完成
不适用
TACE in Combination With PD-1/PD-L1 Inhibitors and Molecular Target Therapies for Advanced HCCHepatocellular CarcinomaNCT05332821Zhongda Hospital1,244
已完成
不适用
Efficacy and Safety of TACE in Combination With ICIs for HCC: a Real-world StudyHepatocellular CarcinomaNCT04975932Zhongda Hospital826